Biotechnology Hart-Scott-Rodino Waiting Period Expires for Halozyme’s Acquisition of Antares Pharma May 12, 2022
Biotechnology BridgeBio Announces Exclusive License Agreement with Bristol Myers Squibb to Develop and Commercialize BBP-398, a Potentially Best-in-Class SHP2 Inhibitor, in Oncology May 12, 2022
Biotechnology Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen’s Oncuria® Bladder Cancer Test May 12, 2022
Biotechnology Bragar Eagel & Squire, P.C. Is Investigating Verra, Cassava, Dentsply Sirona, and Axsome and Encourages Investors to Contact the Firm May 11, 2022
Biotechnology SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates SREV, HMTV, BHVN, SIMO May 11, 2022
Tech Lifshitz Law PLLC Announces Investigations of Chegg, Inc. (NYSE: CHGG), DocuSign, Inc. (NASDAQ: DOCU), Organogenesis Holdings Inc. (NASDAQCM: ORGO), and Reata Pharmaceuticals, Inc. (NASDAQ: RETA) May 11, 2022